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Aims The aim of this study was to determine the relative importance of Ca
2+ sensitization, ion channels, and intracellular
Ca
2+ ([Ca
2+]i) in the mixed constrictor/relaxation actions of superoxide anion on systemic and pulmonary arteries.
Methods
and results
Pulmonaryandmesentericarterieswereobtainedfromrat.Superoxidewasgeneratedinarteriesandcellswith6-anilino-
5,8-quinolinequinone (LY83583). Following pre-constriction with U46619, 10 mmol/L LY83583 caused constriction in
pulmonary and relaxation in mesenteric arteries. Both constrictor and relaxant actions of LY83583 were inhibited by
superoxide dismutase and catalase. LY83583 caused Rho-kinase-dependent constriction in a-toxin-permeabilized pul-
monarybutnotmesentericarteries.Phosphorylationofmyosinphosphatase-targetingsubunit-1(MYPT-1;asdetermined
by western blot), was enhanced by LY83583 in pulmonary arteryonly. However, in both artery types, changesin tension
were closely correlated with changes in phosphorylation of the 20 kDa myosin light chain as well as changes in [Ca
2+]i
(as measured with Fura PE-3), with LY83583 causing increases in pulmonary and decreases in mesenteric arteries.
When U46619 was replaced by 30 mmol/L K
+, all changes in [Ca
2+]i were abolished and LY83583 constricted both
artery types. The KV channel inhibitor 4-aminopyridine abolished the LY83583-induced relaxation in mesenteric artery
without affecting constriction in pulmonary artery. However, LY83583 caused a similar hyperpolarizing shift in the
steady-state activation of KV current in isolated smooth muscle cells of both artery types.
Conclusions Superoxide only causes Rho-kinase-dependent Ca
2+ sensitization in pulmonary artery, resulting in constriction, and
whilst it opens KV channels in both artery types, this only results in relaxation in mesenteric.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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1. Introduction
Reactive oxygen species (ROS) are important second messenger mol-
ecules contributing to normal functioning of multiple cell-signalling
pathways.
1 However, excessive or dysregulated ROS production or
metabolism, termed oxidative stress, promotes enhanced contracti-
lity, vascular smooth muscle growth, and inﬂammation, associated
with numerous cardiovascular diseases, including both systemic
2 and
pulmonary
3,4 hypertension.
Acutely, ROS have complex constricting and relaxing actions on the
systemic vasculature, depending on the artery size, nature of pre-
constriction, amount and type of ROS being generated, and where
it is being generated.
5–8 The two principal ROS produced in living
cells are superoxide anion and its dismutation product hydrogen per-
oxide, and they have distinct actions on the vasculature. Superoxide
inhibits endothelium-dependent relaxation through scavenging of
nitric oxide in both pulmonary and systemic arteries.
2,3,9 Systemically,
hydrogen peroxide may mediate metabolic dilation in the coronary
* Corresponding author. Tel: +44 020 7848 4297; fax: +44 020 7848 3743, Email: greg.knock@kcl.ac.uk
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2010. For permissions please email: journals.permissions@oup.com.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-
commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of
publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.
For commercial re-use, please contact journals.permissions@oup.com.
Cardiovascular Research (2011) 89, 214–224
doi:10.1093/cvr/cvq275circulation
10,11 and may be a candidate endothelium-derived hyper-
polarizing factor (EDHF), a major component of endothelium-
dependent relaxation in resistance sized arteries,
12 acting through
opening of K
+ channels.
5,10,13
For reasons that are not fully understood mechanistically, but may
make sense physiologically because of the need to match perfusion to
ventilation, the pulmonary circulation responds differently to a
number of stimuli, including ROS and hypoxia. In pulmonary arteries
(PAs) hydrogen peroxide is more likely to be pro-contractile,
14 and
EDHF is probably of lesser importance as a component of
endothelium-dependent relaxation than it is systemically.
15,16 PAs
generally constrict in response to hypoxia, whereas systemic arteries
generally relax. ROS are also implicated in this constriction, which, as
a corollary of chronic obstructive pulmonary disease, can cause pul-
monary hypertension (PH), although whether ROS production is
increased or decreased during hypoxia in the pulmonary circulation
remains controversial.
17,18
In addition to the above, both superoxide and hydrogen peroxide
contribute to endothelium-independent constriction through
activation of multiple protein kinase pathways.
19–21 Previously, we
showed that both superoxide and hydrogen peroxide directly con-
stricted rat PA, acting predominantly through Rho-kinase
22 and
protein kinase C (PKC),
14 respectively. Hydrogen peroxide also
causes Ca
2+ release from ryanodine-sensitive stores.
14 ROS-mediated
Rho-kinase activation is also implicated in chronic hypoxia-induced
PH.
23 Superoxide does not directly constrict mesenteric or femoral
arteries, but causes a concentration-dependent constriction/relax-
ation response in the presence of agonist pre-constriction.
22 In the
present study, we set out to determine the nature of the differences
in responses of rat pulmonary and mesenteric arteries (MAs) to
superoxide, comparing the roles of Ca
2+-sensitization, intracellular
Ca
2+ and voltage-gated K
+ channels.
2. Materials and methods
2.1 Reagents and chemicals
Fura PE-3/AM was from Sigma (Poole, UK). L-012, (8-amino-5-chloro-
7-phenylpyrido[3,4-d]pyridazine-1,4-(2H,3H)dione) was from Wako
Chemicals USA, Inc., (USA). Hydrogen peroxide, antioxidant enzymes,
LY83583 (6-anilino-5,8-quinolinequinone), paxilline, tetraethylammonium
(TEA), 4-aminopyridine, and other pharmacological agents were from
Amersham (Bucks, UK), Biomol (Exeter, UK), Calbiochem (Merck
Biosciences Nottingham, UK), Fisher (Loughborough, UK), Invitrogen
(Paisley, UK), Pierce (Cramlington, UK), or Sigma (Poole, UK).
2.2 Animals and tissues
This study conforms with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH Publication
No. 85-23, revised 1996). Housing and handling of animals was also in
accordance with UK Home Ofﬁce regulations. Intra-PA (second to third
order branches) and MAs (second to fourth order) were obtained from
male Wistar rats (200–250 g), killed by pentobarbital injection. Compar-
ably sized coronary and renal arteries were similarly obtained.
2.3 Production and measurement
of superoxide
Superoxide was generated within cells and tissues using LY83583.
24 We
showed previously that this occurs in PASMC using three different
measures of ROS production (MitoSOX, DHE, and L-012).
22 Block with
superoxide dismutase (SOD), but not catalase conﬁrmed superoxide as
the principal species produced.
22 In the present study, we used L-012
(a luminol derivative, 10 mmol/L) to compare levels of ROS production
in PA and MA. Arteries were ﬁrst incubated with L-012 for 30 min for
measurement of a stable baseline before the addition of 1 or 10 mmol/L
LY83583. Luminescence was measured with a luminometer (LKB-1251,
Bromma, Sweden). Luminescence for each LY83583 concentration in
the absence of tissue was subtracted as background, and effects of
treatments quantiﬁed as fold increases above control.
2.4 Measurement of force, intracellular Ca
21
and a-toxin permeabilization
Isometric tension was measured using a wire myograph with arteries
bathed in bicarbonate-buffered physiological salt solution (PSS), at 378C,
pH 7.4, as described previously.
25 In order to facilitate characterization
of both relaxation and constriction responses to LY83583, arteries
were pre-constricted with a concentration of U46619 or KCl that pro-
duced robust, sustainable constrictions of 50–75% or 20–50% the size
of those produced by 80 mmol/L KCl, respectively. Note: Because
several of the other pharmacological agents used also altered constriction
amplitude, the concentrations of U46619 required to generate these pre-
constrictions varied (10–200 nmol/L). Intracellular Ca
2+ ([Ca
2+]i) was
measured in Fura PE-3 loaded, myograph-mounted arteries. Tension
was recorded simultaneously with light emitted by the artery at
.510 nm at excitation wavelengths 340 and 380 nm. The ratio of the
emission intensities (R340/380) was taken as a measure of [Ca
2+]i as
described previously.
26 For Ca
2+-sensitization experiments, myograph-
mounted arteries were permeabilized with a-toxin and Ca
2+-clamped
with 10 mmol/L EGTA, as described previously.
25 In order to obtain a
comparable Ca
2+-induced pre-constriction in PA and MA (i.e. as a per
cent of maximum constriction to pCa 4.5), [Ca
2+]i was ﬁxed at pCa 6.9
in PA and 6.4 in MA. For assessment of endothelial function in responses
to LY83583, myograph-mounted arteries were de-endothelialized by
rubbing the lumen with a human hair (veriﬁed by loss of relaxation to
acetylcholine). Control constrictions revealed no signiﬁcant effects of
vehicle (dimethyl sulphoxide) and no signiﬁcant run-down (not shown).
2.5 Western blot
For measurement of phosphorylation of myosin phosphatase-targeting
subunit-1 (MYPT-1) and the 20 kDa myosin light chain (MLC20), PA or
MA were prepared, treated, and homogenized and protein extracted
for western blot as described previously.
25 Membranes were blocked
for 1 h with 5% skimmed milk, probed with primary antibody overnight
at 48C (1:1000–1:5000 in 1% milk), followed by application of horseradish
peroxidase-conjugated anti-IgG secondary antibody for 1 h at room
temperature (1:5000 in 1% milk). Membranes were ﬁrst probed with
speciﬁc anti-phospho- antibodies, stripped for 1 h (Pierce stripping
buffer), re-blocked, and re-probed with corresponding anti-‘total’ anti-
bodies. Anti-phospho-MYPT-1 (thr-855) was from Upstate (UK), anti-
phospho-MLC20 (ser-19), anti-MLC20, and anti-MYPT-1 were all from
Cell Signalling (UK). HRP-conjugated anti-IgG secondary antibodies
were from Sigma.
2.6 Electrophysiology
For electrophysiology, freshly isolated pulmonary artery smooth muscle
cells (PASMCs) and mesenteric artery smooth muscle cells (MASMCs)
were obtained from third to fourth order PA and MA, respectively, by
enzymatic dispersion, as described previously.
27 Voltage-gated K
+ cur-
rents (KV) were measured by whole-cell voltage-clamp. Cells were super-
fused with HEPES-buffered PSS containing 1 mmol/L paxilline and
10 mmol/L glibenclamide in order to inhibit Ca
2+-activated and KATP cur-
rents, respectively, and dialysed with HEPES-buffered intracellular solution
containing 10 mmol/L EGTA, as described previously.
27
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Data were analysed with SigmaStat (Systat Software, Inc., San Jose, CA,
USA). Simple pair-wise comparisons were done by Student’s t-test. Mul-
tiple comparisons of the effects of treatments against control, of inhibitors
against treatments, and of PA against MA, were performed by one-way or
two-way ANOVA, with pair-wise post-hoc tests, as appropriate. P , 0.05
was deemed signiﬁcant. All data are expressed as mean+SEM.
3. Results
Preliminary experiments showed that, when arteries were pre-
constricted with U46619, 10 mmol/L LY83583 caused near-maximal
constriction in PA, whereas in MA, it caused near-complete relax-
ation. Similarly, 10 mmol/L LY83583 also relaxed U46619-pre-
constricted renal (79.9+7.4% relaxation, n ¼ 2) and coronary
arteries (44.3+13.6% relaxation, n ¼ 5), suggesting that MA is repre-
sentative of the systemic circulation as a whole. 1 mmol/L LY83583
constricted both PA and MA (as shown previously
22). Similar
responses were obtained when arteries were pre-constricted with
phenylephrine (1 mmol/L) instead of U46619 (not shown). In sub-
sequent experiments, we chose to compare responses between PA
and MA in the presence of the NO synthase inhibitor nitro-L-arginine
methyl ester (L-NAME, 1 mmol/L) in order to focus on the
non-NO-related components of the responses to superoxide. The
effects of L-NAME on these responses are presented in Supplemen-
tary material online, Figure S1. All constrictor and relaxation responses
to LY83583 in both PA and MA were unaffected by disruption of the
endothelium (not shown).
3.1 LY83583 generates ROS and mediates
both constriction and relaxation via ROS
As shown in Figure 1A, ROS production was signiﬁcantly increased by
both 1 and 10 mmol/L LY83583 in both PA and MA, with no signiﬁ-
cant differences in fold increases above control between the two
artery types. ROS generation from 10 mmol/L LY83583 was inhibited
by dicoumarol (10 mmol/L), a blocker of the NADPH:quinone oxido-
reductase (diaphorase), in both MA and PA, conﬁrming the intracellu-
lar origin of LY83583-derived ROS.
24 ROS production in MA and PA,
and the similarity between the two, was not signiﬁcantly altered by
the presence of L-NAME (data not shown).
We conﬁrmed that the actions of LY83583 on PA and MA were via
ROS with the use of antioxidant enzymes catalase and SOD. In PA
(Figure 1B, left panels), 10 mmol/L LY83583 enhanced U46619/
L-NAME-induced constriction. This constriction was not signiﬁcantly
affected by catalase alone, but was almost abolished by the combi-
nation of catalase and SOD, and, as shown previously,
22 was signiﬁ-
cantly inhibited by SOD alone (not shown). In MA (Figure 1B, right
panels), 10 mmol/L LY83583 caused a near immediate sustained relax-
ation. In the presence of catalase, there was still a sustained relaxation
but this was preceded by a transient constriction (peaking at
 2.5 min), suggesting that only a part of the relaxation response
was due to hydrogen peroxide. In the combined presence of SOD
and catalase, however, there was no transient constriction, and the
sustained relaxation induced by LY83583 was inhibited. In MA, SOD
alone tended to enhance the rate of relaxation induced by
10 mmol/L LY83583 without revealing a transient constriction (not
shown), consistent with a pro-relaxant effect of the excess hydrogen
peroxide thus generated.
13
3.2 Effects of LY83583 on
Rho-kinase-dependent Ca
21 sensitization
Since we showed previously that superoxide enhances Rho-kinase-
mediated Ca
2+ sensitization in PA,
22 we next examined this
pathway in MA and compared it with PA under similar conditions.
Arteries were permeabilized with a-toxin and [Ca
2+]i clamped at
pCa 6.9 (PA) or 6.4 (MA) to induce a small (10–15% of max) pre-
constriction. In PA, 10 mmol/L LY83583 caused further constriction,
whereas in MA it had no signiﬁcant effect (Figure 2A). Despite these
differences, the Rho-kinase inhibitor Y27632 caused comparable
overall inhibition of these constrictions in the two artery types
(Figure 2A). This comparison suggests that Rho-kinase is basally
active in both artery types, but that LY83583 only inﬂuences activity
of Rho-kinase in PA. However, when a-toxin permeabilized MA
where additionally pre-constricted with U46619/L-NAME, 10 mmol/
L LY83583 caused a small but signiﬁcant relaxation (see Supplemen-
tary material online, Figure S2). This relaxation was clearly smaller
than that seen in non-permeabilized arteries and was abolished by
prior incubation with Y27632 (see Supplementary material online,
Figure S2).
To examine further the relationship between Rho-kinase-mediated
phosphorylation and constriction in the two artery types, the effects
of 1 and 10 mmol/L LY83583 on phosphorylation of MYPT-1 at
thr-855 (speciﬁcally phosphorylated by Rho-kinase in rat vascular
smooth muscle
25,28) and MLC20 at ser-19 were determined. This
was performed in non-permeabilized MA, in order to establish how
closely changes in MYPT-1 phosphorylation were mirrored by
changes in MLC20 phosphorylation under conditions where [Ca
2+]i
was not clamped. As shown in Figure 2B, U46619/L-NAME enhanced
phosphorylation of both MYPT-1 and MLC20 in both PA (left panels)
and MA (right panels). In PA, the further addition of 1 and 10 mmol/L
LY83583 caused further enhancement of phosphorylation of both
proteins. In MA, 1 mmol/L LY83583 had no signiﬁcant effect on
either phosphorylation target, whereas 10 mmol/L slightly (but not
signiﬁcantly) reduced MYPT-1 phosphorylation and greatly reduced
MLC20 phosphorylation (to below basal), in line with the large
relaxations of U46619/L-NAME-pre-constricted MA seen in Figure 1
and see Supplementary material online, Figure S1.
3.3 [Ca
21]i–force relationships
in responses to LY83583
Since LY83583 had limited inﬂuence over Ca
2+ sensitization and
MYPT-1 phosphorylation responses in MA, we next investigated the
relationship between constriction/relaxation responses and [Ca
2+]i
in PA and MA. In PA, when LY83583 was applied cumulatively after
pre-constriction with U46619/L-NAME, it caused stepwise increases
in both constriction and [Ca
2+]i (Figure 3A). In MA, however,
10 mmol/L LY83583 caused a dramatic drop in both constriction
and [Ca
2+]i, whereas 1 mmol/L LY83583 instead caused constriction
and only a small increase in [Ca
2+]i (Figure 3B). Changes in contractile
force in response to LY83583 therefore broadly match changes in
[Ca
2+]i both in PA and MA, particularly at the higher LY83583 con-
centration. To determine whether these changes in [Ca
2+]i were
related to membrane potential, and therefore perhaps to actions on
K
+ channels, we next repeated these experiments, but pre-
constricting with 30 mmol/L K
+ and L-NAME (instead of U46619),
in order to partially dampen the driving force for K
+ efﬂux thus pre-
venting hyperpolarization through opening of K
+ channels. Under
V.A. Snetkov et al. 216these conditions, both PA (Figure 4A) and MA (Figure 4B) were further
constricted in a stepwise fashion by cumulatively applied LY83583,
without any further changes in [Ca
2+]i in either artery type. Constric-
tions induced by LY83583 in the presence of 30 mmol/L K
+ were not
prevented by Y27632 in MA, whereas in PA they were substantially
reduced (see Supplementary material online, Figure S3A). In both
MA and PA, the constriction remaining in the presence of Y27632
was abolished by the PKC inhibitor Go ¨6983 (10 mmol/L) (see
Supplementary material online, Figure S3B).
The fact thatelevated extracellular [K
+] abolished LY83583-induced
[Ca
2+]iresponses(bothincreasesanddecreases)indicatesthatchanges
in [Ca
2+]i were membrane potential-dependent, and that the drop in
[Ca
2+]i in MA induced by 10 mmol/L LY83583 was possibly related to
opening of K
+ channels and subsequent hyperpolarization. We tested
this latter hypothesis by repeating applications of 10 mmol/L LY83583
to U46619/L-NAME pre-constrictions in PA and MA in the absence
or presence of paxilline (1 mmol/L), an inhibitor of Ca
2+-activation
K
+ (BKCa) channels, or 4-aminopyridine (4-AP, 5 mmol/L), an inhibitor
of voltage-gated K
+ (KV) channels. In PA, neither pre-incubation with
paxilline nor with 4-AP had any effect on the sustained constriction
(at 15 min) induced by 10 mmol/L LY83583 (Figure 5A). In MA,
however, paxilline delayed the relaxation response, which was
Figure 1 Vascular effects of LY83583 are via generation of reactive oxygen species. (A, bar chart) Effects of LY83583 (1 mmol/L: 1-LY, 10 mmol/L:
10-LY) on L-012 luminescence, taken as a measure of reactive oxygen species production in mesenteric artery (MA, n ¼ 9–10), and pulmonary artery
(PA, n ¼ 6–21). *P , 0.05 for LY83583 vs. control (artery without LY83583).
†P , 0.05 for dicoumarol (Dic, 10 mmol/L) vs. 10 mmol/L LY83583.
(B) Measurement of tension (mN) in PA (left) and MA (right) pre-constricted for 10–15 min with U46619 (range: 100–200 nmol/L) and
1 mmol/L L-NAME before application of 10 mmol/L LY83583 for a further 15 min alone (PA n ¼ 4, MA n ¼ 12), or in the presence of catalase
(200 U/mL, PA n ¼ 4, MA n ¼ 7) or superoxide dismutase (SOD) and catalase (200 U/mL each, PA n ¼ 4, MA n ¼ 9). Bar charts: Constriction in
PA (left) and MA (right) measured at 15 min before and after application of LY83583, normalized to constriction induced by 80 mmol/L K
+. Asterisk
denotes signiﬁcant constriction (PA) or relaxation (MA) in response to LY83583 (P , 0.01).
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2+-sensitization and phosphorylation of MYPT-1 and MLC20.( A) Measurement of Ca
2+-induced tension (mN) in
a-toxin permeabilized PA (pCa 6.9, left) and MA (pCa 6.4, right). 15 min applications of 10 mmol/L LY83583 caused further constriction in PA (repre-
sentative of 24+5% increase, n ¼ 8), but had no effect in MA (representative of n ¼ 11). In both arteries these constrictions were relaxed by the
Rho-kinase inhibitor Y27632 (10 mmol/L) (PA 81.6+3.3%, n ¼ 8 and MA 69.2+2.9%, n ¼ 11). (B) Example western blots and summary bar charts
showing effects of 1 and 10 mmol/L LY83583 (1 LY or 10 LY) on MYPT-1 and MLC20 phosphorylation in non-permeabilized PA (left) and MA (right),
in the presence of 100 nmol/L U46619 and 1 mmol/L L-NAME (U46/LN). Ratio of phospho/total for each blot was calculated and effects of treatments
expressed as a percentage change over control (untreated artery). Asterisk denotes signiﬁcant enhancement vs. control (P , 0.05, PA n ¼ 10–12, MA
n ¼ 12). Dagger denotes signiﬁcant increase (PA) or decrease (MA) in response to LY83583 compared with U46/LN alone (P , 0.05).
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whereas 4-AP virtually abolished the relaxation (Figure 5B). Neither
paxilline nor 4-AP had any effects on un-pre-constricted PA or MA
(not shown). 1 mmol/LTEA had a similar effect on LY83583 responses
to that of paxilline (not shown).
3.4 Effects of LY83583 on voltage-gated
K
1 currents
In order to conﬁrm that inhibition of 10 mmol/L LY83583-induced
relaxation in MA by 4-AP was through inhibition of KV channels, we
examined the effects of LY83583 on KV currents in freshly isolated
MASMC by whole-cell voltage-clamp and compared them with
PASMC. We examined the steady-state activation characteristic (VA)
of the current by applying a range of pre-conditioning potentials
and then brieﬂy stepping to an appropriate test potential and measur-
ing the amplitude of the resultant tail current. As shown in Figure 6,
LY83583 caused a signiﬁcant hyperpolarizing shift in VA in both MA
and PA, with no signiﬁcant difference in the size of the shift
between the two cell-types (213.7+2.3 mV in MA and 210.8+
1.7 mV in PA).
Figure 3 Effects of LY83583 on relationship between constriction and [Ca
2+]i with U46619 pre-constriction. Example traces: Simultaneous
measurement of tension (mN) and [Ca
2+]i (R340/380)i nP A( A) and MA (B). Following pre-constriction with 100 nmol/L U46619 and 1 mmol/L
L-NAME, LY83583 was added cumulatively at 10 min intervals, as indicated. Note: constriction and [Ca
2+]i responses returned to the pre-constriction
level when LY83583 was washed out in the continued presence of U46619/L-NAME. Summary charts: effects of LY83583 on [Ca
2+]i (open symbols)
and constriction (closed symbols), normalized to responses induced by 80 mmol/L K
+,i nP A( A, n ¼ 4–5) and MA (B, n ¼ 4). Note: charts do not
show effects of washout. Asterisk denotes signiﬁcant enhancement or reduction of tension or [Ca
2+]i compared with the zero time-point (P , 0.05).
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in responses to LY83583
Since LY83583 may also inﬂuence vascular tone through inhibition of
guanylyl cyclase, either directly or via ROS,
29 we examined responses
to LY83583 in PA and MA in the presence of the guanylyl cyclase
inhibitor ODQ (10 mmol/L). ODQ greatly enhanced the sensitivity
of both artery types to U46619 (not shown), making it exceedingly
difﬁcult to match pre-constriction amplitudes to those obtained
without ODQ, despite a reduction in U46619 concentration.
Nevertheless, when pre-constricted with U46619/L-NAME/ODQ,
both 1 and 10 mmol/L LY83583 still caused constriction in PA, and
10 mmol/L still caused relaxation in MA. However, 1 mmol/L was
without effect in MA under these conditions (see Supplementary
material online, Figure S4; compare with Figure 3).
4. Discussion
Our data show that in the presence of the prostanoid agonist U46619,
superoxide (as generated by LY83583
24) constricts PA and causes
either constriction or relaxation in MA, dependent on concentration.
Figure 4 Effects of LY83583 on relationship between constriction and [Ca
2+]i with sub-maximal K
+ pre-constriction. Example traces: Simultaneous
measurement of tension (mN) and [Ca
2+]i (R340/380)i nP A( A) and MA (B). Following pre-constriction with 30 mmol/L KCl and 1 mmol/L L-NAME,
LY83583 was added cumulatively at 10 min intervals, as indicated. Note: constriction and [Ca
2+]i responses returned to the pre-constriction level
when LY83583 was washed out in the continued presence of U46619/L-NAME. Summary charts: effects of LY83583 on [Ca
2+]i (open symbols)
and constriction (closed symbols), normalized to responses induced by 80 mmol/L K
+ in PA (A, n ¼ 4–6) and MA (B, n ¼ 4–5). Note: charts do
not show effects of washout. Asterisk denotes signiﬁcant enhancement of tension or [Ca
2+]i compared with the zero time-point (P , 0.01).
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of L-NAME, and are largely unaffected by ODQ. This suggests there-
fore, notwithstanding the importance of NO scavenging and guanylyl
cyclase activity to endothelium-dependent relaxation,
2,3,9 that there
are additional pathways through which ROS can inﬂuence vascular
tone. MAs are likely to be representative of the systemic circulation
as a whole since we also observed superoxide-induced relaxation in
agonist pre-constricted coronary and renal arteries.
Ca
2+ sensitization is the process through which an increased con-
tractile force can be achieved without a concomitant increase in
[Ca
2+]i and is thought to be present to varying degrees in all
smooth muscles.
30 One way in which this occurs is through the
MYPT-1 which, when phosphorylated on thr-855, primarily by Rho-
kinase, causes inhibition of myosin phosphatase, thus enhancing
MLC20 phosphorylation.
28,30 In LY83583-stimulated PA, we observe a
close correlation between MYPT-1 phosphorylation, MLC20 phos-
phorylation and Y27632-sensitive constriction, suggestive of
Rho-kinase-dependent Ca
2+ sensitization. In MA, we observe an appar-
ent dissociation between MYPT-1 phosphorylation and MLC20 phos-
phorylation (and hence constriction) during responses to superoxide;
Figure 5 Effects of K
+ channel blockers on LY83583-induced constriction and relaxation. Measurements of tension (mN) in PA (A) and MA (B)
pre-constricted for 10–15 min with U46619 (range: 10–100 nmol/L) and 1 mmol/L L-NAME. Example traces show effects of 10 mmol/L LY83583
in the absence (control) and presence of BKCa channel blocker paxilline, (1 mmol/L) or KV channel blocker 4-aminopyridine (4-AP, 5 mmol/L). As
shown in summary bar charts, signiﬁcant enhancement of constriction caused by LY83583 in PA (A) was unaffected by either paxilline or 4-AP
(*P , 0.05 vs. U46/LN alone, n ¼ 4–6). In contrast, signiﬁcant relaxation caused by LY83583 in MA (B) was only delayed by paxilline but abolished
by 4-AP (*P , 0.01 vs. U46/LN alone, n ¼ 6–12).
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despite a profound drop in MLC20 phosphorylation and an associated
relaxation. Similarly, the rather small relaxation induced by LY83583 in
a-toxin permeabilized MA, apparently mediated through inhibition of
Rho-kinase (and therefore indicative of a small degree of superoxide-
mediated Ca
2+-de-sensitization), was not large enough to account
for the near complete relaxation observed in non-permeabilized MA.
These observed differences between MA and PA are curious when
considering that, as far as is known, Rho-kinase is of similar importance
to normal and hypertensive systemic blood pressure
31,32 as it is to the
pulmonary circulation.
33,34 Although the importance of Rho-kinase in
the mesenteric circulation reportedly diminishes with the size of the
artery,
31 Ca
2+-induced constrictions in a-toxin permeabilized PA and
MA were similarly inhibited by the blocker of Rho-kinase, Y27632.
These results suggest that either the sensitivity of the Rho-kinase
pathway to ROS is less in MA than in PA, perhaps through differences
in upstream signalling (e.g. src-family kinases
25) or, as discussed below,
that ROS-induced vascular tone in MA is more dependent on other
forms of Ca
2+ sensitization, or on ion channels that inﬂuence MLC20
phosphorylation through changes in [Ca
2+]i.
Figure 6 Effects of LY83583 on steady-state activation of voltage-gated K
+ currents. Voltage protocols: cells serially subjected to a range of pre-
conditioning pulses between 260 and +60 mV, each followed by a short test pulse to 220 mV (A, PASMC) or 0 mV (B, MASMC). Representative
traces: tail currents evoked at relevant test potential before (control) and during application of LY83583 (10 mmol/L for 10 min). Note: different test
potentials were chosen for ease of measurement of much smaller currents in MASMC. Arrows indicate point at which measurements were taken.
Main summary plots: Tail current measurements from PASMC (A, n ¼ 5) and MASMC (B, n ¼ 6), normalized to maximum current amplitude,
plotted against conditioning potential and ﬁtted by Boltzmann non-linear regression. Inset bar-charts: VA calculated from Boltzmann ﬁt in PASMC
(A,* P , 0.01 vs. control) and MASMC (B,* P , 0.01 vs. control). Note: all currents recorded in the presence of 1 mmol/L paxilline and 10 mmol/L
glibenclamide to block BKCa and KATP channels.
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LY83583 in MA in the presence of U46619 mirrored the changes in
arterial tension in non-permeabilized MA, and were matched by
similar changes in [Ca
2+]i. The close relationship between [Ca
2+]i
and constriction was abolished by replacing U46619 with 30 mmol/
LK
+, thus converting the LY83583-induced relaxation in MA to con-
striction, and crucially abolishing the main differences between MA
and PA. This experiment raises several interesting points. First, it
clearly suggests that superoxide was lowering [Ca
2+]i and inducing
relaxation in MA via opening of K
+ channels and subsequent hyperpol-
arization, as shown previously with hydrogen peroxide, which hyper-
polarizes mesenteric and coronary arteries predominantly through
actions on KV channels,
5,10 although BKCa channels may also be
affected.
35 Our observation that LY83583-induced relaxation was abol-
ished by 4-AP or the combination of SOD and catalase, but only par-
tially blocked by paxilline, TEA, or catalase alone, suggests that both
superoxide and hydrogen peroxide contribute to the
hyperpolarization, but that the principle K
+ channel type acted upon
was KV, with at best a minor contribution from BKCa. The lack of
effect of ODQ on LY83583-induced relaxation in MA rules out the
possibility that this relaxation is via ROS-mediated guanylyl cyclase
activation and subsequent PKG-mediation K
+ channel opening.
In light of the fact that LY83583 was unable to relax PA, it was
somewhat surprising that it caused a similar shift in the steady-state
activation of the KV current in PASMC as it did in MASMC.
However, the inability of 4-AP to prevent LY83583 from causing con-
striction in PA also refutes the supposition that ROS differentially
modulate KV channel activity in PA (inhibition) and MA (activation).
Recently, a direct comparison of KV channel characteristics in the
two cell-types suggested that channels of this family are more numer-
ous in PASMC, are more likely to be open in the negative range of
membrane potentials, and are therefore more likely to contribute
to resting membrane potential in PASMC than in MASMC.
27 Although
this implies that blocking the KV current would be expected to cause
more depolarization and a larger elevation of [Ca
2+]i in PA than in
MA, it is apparent that this depolarization in itself is not enough to
cause constriction, since 4-AP alone, while enhancing agonist-induced
constriction, does not directly constrict either PA or MA. Another
question arising from this is whether opening KV channels is generally
more likely to overcome U46619-induced depolarization and con-
striction in MA than in PA, and if so, why. An answer to this question
may explain why physiological agents that affect membrane potential,
such as EDHF, have more of an inﬂuence on [Ca
2+]i and constriction
in systemic compared with PAs.
13,15 We previously reported that
LY83583 does not elevate [Ca
2+]i in PA in the absence of agonist;
22
however, in the present study it caused further increases above that
induced by U46619. Elevated extracellular [K
+] clearly prevented
these LY83583-induced increases in [Ca
2+]i in PA, suggesting the
increase was due to Ca
2+ inﬂux rather than release from stores (as
shown for hydrogen peroxide
14). Non-selective cation channels
(NSCC) may be directly ROS sensitive,
36 and we showed that agonist-
mediated contractions are more dependent on La
3+-sensitive NSCC
in PA, but more dependent on voltage-gated Ca
2+ channels in MA.
37
NSCC may therefore contribute to LY83583-induced Ca
2+ inﬂux in
PA. Either way, this Ca
2+ inﬂux, in addition to the enhanced
Rho-kinase-mediated Ca
2+ sensitization, may be enough to selectively
overcome opening of KV channels and cause constriction in PA.
The apparent independence of [Ca
2+]i and constriction from KV
channel opening in response to superoxide in PA is of relevance to
hypoxic pulmonary vasoconstriction (HPV) and chronic hypoxia-
induced PH. One proposed mechanism for HPV is that hypoxia
causes a reduction in ROS production and this relieves a constitutive
redox activation of KV channels, thus causing depolarization and Ca
2+
inﬂux.
17 Our data, although agreeing that ROS enhance KV current in
PA, imply that at least in the presence of a depolarizing and Ca
2+-
sensitizing agonist, it is irrelevant to constriction. Rather, our results
are consistent with the alternative hypothesis that an increased pro-
duction of mitochondrial ROS during hypoxia causes increases in
both [Ca
2+]i and Rho-kinase-mediated Ca
2+ sensitization which
mediate HPV.
18,38 This is also relevant to a rat model of chronic
hypoxia-induced PH, where a direct link has been made between
enhanced superoxide production, Rho-kinase activation and enhanced
PA contractility.
23
In MA pre-constricted with U46619, 1 mmol/L LY83583 did not
elevate MYPT-1 phosphorylation or [Ca
2+]i but it nevertheless
caused constriction. This constriction was also abolished by prior inhi-
bition of guanylyl cyclase. These results suggest that, at this concen-
tration, LY83583 is constricting MA independently of direct
Rho-kinase activation. Futhermore, when pre-constricted with K
+
instead of U46619, the resultant Ca
2+-independent LY83583-induced
constrictions were much less sensitive to Y27632 in MA than in PA,
but were blocked by a PKC inhibitor. This all suggests an alternative
form of ROS-sensitive Ca
2+-sensitization that has a stronger inﬂuence
over tone in MA than in PA. While this differential involvement of
PKC is interesting, particularly since it too is implicated in ROS-
mediated constriction,
14,19 further analysis of the role of PKC in this
constriction is beyond the scope of this study. Furthermore, why
similar constrictions did not also occur in a-toxin permeabilized
MA and how guanylyl cyclase/protein kinase G may be involved
without interaction with Rho-kinase, remain undetermined.
In summary, we observed effects of superoxide on both pro-
contractile and pro-relaxant pathways in both MA and PA. Rho-kinase
Ca
2+-sensitization and Ca
2+-inﬂux pathways were only signiﬁcantly
activated in PA. An alternative pro-contractile pathway responsive
to the lower concentration of LY83583, possibly involving PKC, was
more prominent in MA. However, the Kv current was enhanced in
both PA and MA. These pathways combine to give a net response
to the higher concentration of LY83583 of relaxation in MA and con-
striction in PA. This suggests a fundamental difference in the way basic
signalling pathways interact and which ultimately have a greater inﬂu-
ence over MLC20 phosphorylation and tone. A better understanding
of these differences may help with the development of anti-
hypertensive therapies designed to speciﬁcally target the pulmonary
or systemic vasculature.
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